A detailed history of United Capital Management Of Ks, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, United Capital Management Of Ks, Inc. holds 12,239 shares of LLY stock, worth $10.7 Million. This represents 2.64% of its overall portfolio holdings.

Number of Shares
12,239
Previous 12,272 0.27%
Holding current value
$10.7 Million
Previous $9.55 Million 16.06%
% of portfolio
2.64%
Previous 2.31%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $23,920 - $29,998
-33 Reduced 0.27%
12,239 $11.1 Million
Q1 2024

Apr 19, 2024

SELL
$592.2 - $792.28 $59,220 - $79,228
-100 Reduced 0.81%
12,272 $9.55 Million
Q4 2023

Jan 25, 2024

SELL
$525.19 - $619.13 $193,269 - $227,839
-368 Reduced 2.89%
12,372 $7.21 Million
Q3 2023

Nov 03, 2023

BUY
$434.7 - $599.3 $3.41 Million - $4.7 Million
7,846 Added 160.32%
12,740 $6.84 Million
Q2 2023

Aug 04, 2023

SELL
$350.74 - $468.98 $101,714 - $136,004
-290 Reduced 5.59%
4,894 $2.3 Million
Q1 2023

Apr 27, 2023

SELL
$310.63 - $364.82 $122,698 - $144,103
-395 Reduced 7.08%
5,184 $1.78 Million
Q4 2022

Jan 31, 2023

SELL
$321.55 - $374.67 $93,249 - $108,654
-290 Reduced 4.94%
5,579 $2.04 Million
Q3 2022

Oct 31, 2022

SELL
$296.48 - $337.87 $37,060 - $42,233
-125 Reduced 2.09%
5,869 $1.9 Million
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $174,763 - $205,198
-627 Reduced 9.47%
5,994 $1.94 Million
Q1 2022

Apr 26, 2022

SELL
$234.69 - $291.66 $32,387 - $40,249
-138 Reduced 2.04%
6,621 $1.9 Million
Q4 2021

Jan 18, 2022

BUY
$224.85 - $279.04 $24,058 - $29,857
107 Added 1.61%
6,759 $1.87 Million
Q3 2021

Oct 27, 2021

SELL
$221.6 - $272.71 $63,820 - $78,540
-288 Reduced 4.15%
6,652 $1.54 Million
Q2 2021

Jul 26, 2021

BUY
$180.55 - $233.54 $42,609 - $55,115
236 Added 3.52%
6,940 $1.59 Million
Q1 2021

Apr 27, 2021

SELL
$164.32 - $212.72 $17,253 - $22,335
-105 Reduced 1.54%
6,704 $1.25 Million
Q4 2020

Jan 21, 2021

BUY
$130.46 - $172.63 $26,613 - $35,216
204 Added 3.09%
6,809 $1.15 Million
Q3 2020

Oct 19, 2020

BUY
$146.22 - $169.13 $103,377 - $119,574
707 Added 11.99%
6,605 $977,000
Q2 2020

Jul 17, 2020

BUY
$136.42 - $164.18 $47,064 - $56,642
345 Added 6.21%
5,898 $968,000
Q1 2020

May 04, 2020

BUY
$119.05 - $147.35 $30,357 - $37,574
255 Added 4.81%
5,553 $770,000
Q4 2019

Jan 24, 2020

BUY
$106.92 - $132.43 $58,164 - $72,041
544 Added 11.44%
5,298 $696,000
Q3 2019

Oct 15, 2019

BUY
$106.79 - $116.16 $24,668 - $26,832
231 Added 5.11%
4,754 $513,000
Q2 2019

Jul 25, 2019

BUY
$110.79 - $129.32 $16,840 - $19,656
152 Added 3.48%
4,523 $510,000
Q1 2019

May 01, 2019

BUY
$111.31 - $131.02 $49,644 - $58,434
446 Added 11.36%
4,371 $516,000
Q4 2018

Jan 10, 2019

BUY
$105.9 - $118.64 $415,657 - $465,662
3,925 New
3,925 $454,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $834B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track United Capital Management Of Ks, Inc. Portfolio

Follow United Capital Management Of Ks, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Management Of Ks, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Capital Management Of Ks, Inc. with notifications on news.